Lung transplantation for alpha 1-antitrypsin deficiency emphysema.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8989166.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lung transplantation is an option for appropriately selected patients with end-stage emphysema caused by alpha 1-antitrypsin deficiency. The functional results have been excellent after single or bilateral lung transplantation, and the medium-term survival results have been good. However, the role of alpha 1-antitrypsin replacement therapy after lung transplantation remains uncertain, and further investigation is needed.
Medical subject headings
- Lung Transplantation
- Pulmonary Emphysema
- alpha 1-Antitrypsin Deficiency